ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Edge Therapeutics, Inc.

Edge Therapeutics, Inc. (EDGE)

0,5036
0,00
(0,00%)
Fermé 10 Février 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
0,5036
Prix Achat
0,50
Prix Vente
0,53
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
0,5036
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

EDGE Dernières nouvelles

Edge Therapeutics Announces Full Year 2018 Financial Results

BERKELEY HEIGHTS, N.J., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE) today announced financial results for the full-year ended December 31, 2018. Financial Results...

Edison issues update on NetScientific (NSCI)

LONDON, Nov. 30, 2018 (GLOBE NEWSWIRE) -- In late November 2018, NetScientific (AIM: NSCI) announced that its portfolio company PDS Biotechnology and Edge Therapeutics (NASDAQ: EDGE) will...

Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company

-Merger would create publicly-traded immuno-oncology biotechnology company developing novel products for treating early- and late-stage cancer- -Growing product pipeline utilizing Versamune®, a...

Edge Therapeutics Reports Third Quarter 2018 Financial Results

BERKELEY HEIGHTS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE) today announced financial results for the quarter ended September 30, 2018. Third Quarter...

Edge Therapeutics Reports Second Quarter 2018 Financial Results

BERKELEY HEIGHTS, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE) today announced financial results for the quarter ended June 30, 2018. Second Quarter...

Edge Therapeutics Announces Updated Results from Phase 3 NEWTON 2 Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage

BERKELEY HEIGHTS, N.J., June 27, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE) today announced updated results from its ongoing analyses of the Phase 3 NEWTON 2 study of...

DEADLINE REMINDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. &...

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Edge Therapeutics, Inc. (“Edge” or ''the Company'') (NASDAQ:...

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. ...

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Edge Therapeutics, Inc. (“Edge” or ''the Company'') (NASDAQ:...

Edge Therapeutics Reports First Quarter 2018 Financial Results

BERKELEY HEIGHTS, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE) today announced financial results for the quarter ended March 31, 2018. First Quarter...

Edge Therapeutics Announces Review of Strategic Alternatives

BERKELEY HEIGHTS, N.J., April 30, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE) today announced that its Board of Directors is conducting a comprehensive review of strategic...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

EDGE - Frequently Asked Questions (FAQ)

What is the current EDGE THERAPEUTICS, INC. share price?
The current share price of EDGE THERAPEUTICS, INC. is US$ 0,5036
What is the 1 year trading range for EDGE THERAPEUTICS, INC. share price?
EDGE THERAPEUTICS, INC. has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
CDTConduit Pharmaceuticals Inc
US$ 2,831
(82,65%)
144,17M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
TOIIWOncology Institute Inc
US$ 0,033
(58,88%)
7,27k
CYTHCyclo Therapeutics Inc
US$ 1,19
(54,55%)
84,73M
FTELFitell Corporation
US$ 2,70
(-57,01%)
2,3M
SGBXSafe and Green Holdings Corporation
US$ 0,6401
(-44,82%)
5,65M
NKLANikola Corporation
US$ 0,4432
(-41,10%)
52,44M
PLRXPliant Therapeutics Inc
US$ 7,785
(-34,85%)
6,44M
LIPOLipella Pharmaceuticals Inc
US$ 3,08
(-33,76%)
2,2M
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
RIMEAlgorhythm Holdings Inc
US$ 0,0169
(-20,66%)
274,2M
NVDANVIDIA Corporation
US$ 129,84
(0,90%)
228,2M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0537
(14,74%)
212,29M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock